Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W James

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Redox Biology|February 26, 2023
Selenium nanoparticles modulate histone methylation via lysine methyltransferase activity and S-adenosylhomocysteine depletionBenoit Toubhans, Nour Alkafri, Marcos Quintela, et al.
British Journal of Cancer|April 29, 2023
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancerMarcos Quintela, David W James, Jetzabel Garcia, et al.
Frontiers in Cell and Developmental Biology|February 20, 2025
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasionLydia C Powell, Marcos Quintela, David W James, et al.
Molecular Cancer Therapeutics|March 7, 2026
Distinct H3K27 methylation states drive cellular responses to the histone demethylase inhibitor GSK-J4 in ovarian cancer cellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Molecular Cancer Therapeutics|April 27, 2026
Distinct H3K27 Methylation States Drive Cellular Responses to the Histone Demethylase Inhibitor GSK-J4 in Ovarian Cancer CellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Clinical Epigenetics|April 14, 2023
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cellsMarcos Quintela, David W James, Agne Pociute, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Redox Biology|February 26, 2023
Selenium nanoparticles modulate histone methylation via lysine methyltransferase activity and S-adenosylhomocysteine depletionBenoit Toubhans, Nour Alkafri, Marcos Quintela, et al.
British Journal of Cancer|April 29, 2023
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancerMarcos Quintela, David W James, Jetzabel Garcia, et al.
Frontiers in Cell and Developmental Biology|February 20, 2025
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasionLydia C Powell, Marcos Quintela, David W James, et al.
Molecular Cancer Therapeutics|March 7, 2026
Distinct H3K27 methylation states drive cellular responses to the histone demethylase inhibitor GSK-J4 in ovarian cancer cellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Molecular Cancer Therapeutics|April 27, 2026
Distinct H3K27 Methylation States Drive Cellular Responses to the Histone Demethylase Inhibitor GSK-J4 in Ovarian Cancer CellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Clinical Epigenetics|April 14, 2023
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cellsMarcos Quintela, David W James, Agne Pociute, et al.
Pageof 2